Clearside Biomedical, Inc. (CLSD)
USD 0.77
(3.23%)
USD 0.77
(3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.13 Million | -13.36 Million | -10.73 Million | -13.12 Million | -27.06 Million | -79.2 Million |
| Net Income | -32.48 Million | -32.94 Million | 376 Thousand | -18.21 Million | -30.77 Million | -82.81 Million |
| Depreciation & Amortization | 67 Thousand | 145 Thousand | 178 Thousand | 180 Thousand | 211 Thousand | 189 Thousand |
| Deferred income taxes | -394 Thousand | - | - | - | -52 Thousand | -748 Thousand |
| Stock-based compensation | 4.2 Million | 4.88 Million | 5.05 Million | 3.6 Million | 4.61 Million | 4.78 Million |
| Change in working capital | 720 Thousand | 11.23 Million | -15.34 Million | 1.12 Million | -1.29 Million | -874 Thousand |
| Other non-cash items | 9.75 Million | 3.31 Million | -998 Thousand | 188 Thousand | 230 Thousand | 266 Thousand |
| Investing Cash Flow | -1.77 Million | -246 Thousand | - | -55 Thousand | 32.92 Million | -3.76 Million |
| Investments in PPE | -1.77 Million | -246 Thousand | - | -55 Thousand | -25 Thousand | -88 Thousand |
| Acquisitions | - | - | - | - | - | -660 Thousand |
| Investment purchases | - | - | - | - | - | -80.14 Million |
| Sales/Maturities of investments | - | - | - | - | 32.95 Million | 76.47 Million |
| Other Investing Activities | -2.3 Million | -528 Thousand | - | -55 Thousand | 32.94 Million | 660 Thousand |
| Financing Cash Flow | 414 Thousand | 31.33 Million | 23.78 Million | 7.86 Million | 8.69 Million | 81.77 Million |
| Debt repayment | - | -30.63 Million | - | -5.34 Million | -5 Million | -8.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.76 Million | 695 Thousand | 23.78 Million | 11.95 Million | 13.64 Million | 79.56 Million |
| Other Financing Activities | -1.35 Million | 31.33 Million | 23.78 Million | 1.24 Million | 52 Thousand | 10.51 Million |
| Accounts receivables | -220 Thousand | 10.42 Million | -10.86 Million | 1.89 Million | - | - |
| Accounts payables | 614 Thousand | 694 Thousand | 681 Thousand | -631 Thousand | -5.58 Million | -314 Thousand |
| Inventory | - | - | -681 Thousand | -1.26 Million | - | - |
| Other working capital | 326 Thousand | 122 Thousand | -4.47 Million | 1.12 Million | 4.28 Million | -560 Thousand |
| Cash at beginning of period | 48.41 Million | 30.69 Million | 17.64 Million | 22.95 Million | 8.4 Million | 9.58 Million |
| Cash at end of period | 28.92 Million | 48.41 Million | 30.69 Million | 17.64 Million | 22.95 Million | 8.4 Million |
| Capital Expenditure | -1.77 Million | -246 Thousand | - | -55 Thousand | -25 Thousand | -88 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -19.49 Million | 17.72 Million | 13.04 Million | -5.3 Million | 14.55 Million | -1.18 Million |
| Free Cash Flow | -19.91 Million | -13.61 Million | -10.73 Million | -13.17 Million | -27.09 Million | -79.28 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.59 Million | -11.76 Million | -4.83 Million | -32.48 Million | -9.26 Million | -9.1 Million |
| Depreciation & Amortization | 44 Thousand | 28 Thousand | 20 Thousand | 67 Thousand | 16 Thousand | 16 Thousand |
| Deferred income taxes | - | - | -419 Thousand | -394 Thousand | - | - |
| Stock-based compensation | 1.12 Million | 1.06 Million | 1.02 Million | 4.2 Million | 1.07 Million | 1.06 Million |
| Change in working capital | 437 Thousand | -1.08 Million | 2 Million | 720 Thousand | -520 Thousand | 396 Thousand |
| Other non-cash items | 1.5 Million | 6.13 Million | 2.69 Million | 9.75 Million | 2.62 Million | 2.29 Million |
| Investing Cash Flow | -11.43 Million | -57 Thousand | -120 Thousand | -1.77 Million | -445 Thousand | -1.09 Million |
| Investments in PPE | -423 Thousand | -57 Thousand | -120 Thousand | -1.77 Million | -445 Thousand | -1.09 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -11.01 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -11.01 Million | -220 Thousand | -2.3 Million | -2.3 Million | - | - |
| Financing Cash Flow | - | 14.34 Million | -257 Thousand | 414 Thousand | 317 Thousand | 22 Thousand |
| Debt repayment | - | -450 Thousand | -923 Thousand | - | -266 Thousand | -362 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 21 Thousand | - | - | - | - | - |
| Common Stock Issuance | 4.32 Million | 13.89 Million | 1.66 Million | 1.76 Million | 266 Thousand | 362 Thousand |
| Other Financing Activities | - | 483 Thousand | -1 Million | -1.35 Million | 317 Thousand | 22 Thousand |
| Accounts receivables | - | - | -220 Thousand | -220 Thousand | - | - |
| Accounts payables | 19 Thousand | -1.11 Million | 647 Thousand | 614 Thousand | 752 Thousand | 282 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 418 Thousand | 30 Thousand | 1.35 Million | 326 Thousand | -1.27 Million | 114 Thousand |
| Cash at beginning of period | 35.35 Million | 28.92 Million | 28.8 Million | 48.41 Million | 35 Million | 41.41 Million |
| Cash at end of period | 18.23 Million | 35.35 Million | 28.92 Million | 28.92 Million | 28.8 Million | 35 Million |
| Capital Expenditure | -423 Thousand | -57 Thousand | -120 Thousand | -1.77 Million | -445 Thousand | -1.09 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -17.11 Million | 6.43 Million | 118 Thousand | -19.49 Million | -6.2 Million | -6.41 Million |
| Free Cash Flow | -6.1 Million | -7.9 Million | 375 Thousand | -19.91 Million | -6.52 Million | -6.43 Million |
TWD
EZTD
PCMC
FTTRF
SBGLP
PTCO